UK MHRA · October 16, 2025

Guidance: AI Airlock Phase 2 Cohort

Phase 2 of the Airlock programme will include seven additional AI-powered technologies for clinical documentation, cancer diagnostics, eye disease detection, and obesity treatment.

High obligation Sector Digital Health & AI Medical Devices & IVD UK Software as a medical deviceAI governanceDigital therapeutics

Phase 2 of the Airlock will include seven additional technologies spanning AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection tools, and obesity treatment support systems.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.